Clinical significance of morphologic characteristics in triple negative breast cancer
Authors:
Open Access
- 1 January 2011
- journal article
- Published by The Korean Surgical Society in Journal of the Korean Surgical Society
- Vol. 80 (5) , 301-306
Abstract
Ryu DW, et al. J Korean Surg Soc. 2011 May;80(5):301-306. http://dx.doi.org/10.4174/jkss.2011.80.5.301Keywords
This publication has 24 references indexed in Scilit:
- Basal-Like Breast Cancer: A Critical ReviewJournal of Clinical Oncology, 2008
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerJournal of Clinical Oncology, 2008
- The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 2007
- Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFRAmerican Journal of Surgical Pathology, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiationThe Journal of Pathology, 2006
- Breast Cancer Molecular Subtypes Respond Differently to Preoperative ChemotherapyClinical Cancer Research, 2005
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Molecular portraits of human breast tumoursNature, 2000
- Large, Central Acellular Zones Indicating Myoepithelial Tumor Differentiation in High-Grade Invasive Ductal Carcinomas as Markers of Predisposition to Lung and Brain MetastasesAmerican Journal of Surgical Pathology, 2000